Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'll wait till the end of the year, how's that timeframe? By then, I'm sure a trial or two would have started, which then starts the timer for data readout 3 months later for some indications.
I even speculate the reasons as to why only 750 then 375 shares are being purchased. That's another post though. ????
And a year or two ago, wasn't this the topic of discussions for a while. Why even have placebo when there was enough data to provide a historical placebo. It's cruel to give participants false hope.
Then the naysayers insisted that unless its blinded, it doesn't hold much weight.
Now look at 21cca and how they blew that theory out of the water.
Positive Data will move the company up or down, and until there is factual evidence that a-273 and the drugs beyond that is a failure, I'll continue to hold. All else, is just games the market play. Like that link to some "insider" source about a top secret meeting between Anavex and PFE.
I wouldn't say we all would rather have news, because I could care less WHEN he is ready to take the next step forward. Could be tomorrow, next week, or next month. Bottom line is when he feels like the company is ready for its next step forward, only then will he move forward.
You do understand that if a-273 even halts the decline, we are a threat to ALL BP, right?
You don't think they are waiting for the same data that we are?
Same hint that a-273 just might be the SOC?
Another week of Missling purchasing.
375 Shares
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12276604&RcvdDate=9/11/2017&CoName=ANAVEX%20LIFE%20SCIENCES%20CORP.&FormType=4&View=html
Sorry if it was posted earlier
Firstly, thank you for bringing to our attention the link you provided. It's information about the co that the investor decides if it means anything or not. It's not anyone on the board that makes the final decision on what to do with said investment. Each takes what speculation is given and decides what to do with it. It's why I enjoy reading MOST posts on the board.
Then there's the 1's and 2's. ; )
Do they even count as a credible source?
I know I would count them as anything BUT credible.
Of course they are. Give one reason why they wouldn't be?
What other drug restores homeostasis?(According to whats been shared with us from PR and/or conferences)
Better yet, I'll just post a quick copy and paste on symptoms of MS and see in what areas a-273 could help according to what has been put out from the p2a/b clinical trial so far.
Pain areas: in the back or eyes
Pain circumstances: can occur in the back due to head nod or with eye movement
Whole body: fatigue, dizziness, heat intolerance, poor balance, vertigo, or weakness
Sensory: pins and needles, abnormality of taste, reduced sensation of touch, or uncomfortable tingling and burning
Urinary: excessive urination at night, leaking of urine, persistent urge to urinate, or urinary retention
Visual: blurred vision, double vision, or vision loss
Sexual: erectile dysfunction or sexual dysfunction
Mood: anxiety or mood swings
Speech: slurred speech or impaired voice
Also common: constipation, depression, difficulty swallowing, difficulty thinking and understanding, flare, headache, heavy legs, limping, numbness of face, rapid involuntary eye movement, sleep deprivation, tongue numbness, or difficulty raising the foot
Are we done with an "important" person leaving the co and needing a PR for it?
I'm expecting help in the form of 21cca.
With that, it's anyone's guess as to how government would or would not help a possible drug that has the potential to keep Medicare and Medicaid alive vs below water.
See my previous post explaining exactly this as to why I wouldn't take a buyout. Microsoft style is the way to the riches if this plays out the way MOST of us here are hoping.
None. Better to be surprised than setting yourself up for disappointment.
There wasn't one of him joining back in August of 2016, so why would there be one of him leaving? He worked there for 1 year 2 months, almost the same month BIIB started testing a-273, and we are making a big deal as if he was there from day 1 because.....?
He could have gotten a better compensation package for all we know.
It's about the drug anyway, no matter who comes and goes along the way.
Same as you can't assume it'll be worse, or that he left knowing something bad was about to happen.
I hope the goal isn't to panic people before a conference with speculation. ??
Isn't the 26 an investment conference just like he attended last year?
It wouldn't even make it to 6 months before it got approved if the next trial can replicate p2a/b.
As in the words of a select poster, "This has been discussed on the board previously." = )
I'd be slightly annoyed. Bill Gates didn't get his fortune from selling Microsoft. He got it by licensing it out individually.
Why wouldn't Anavex want to let everyone have a piece of the pie, as long as they have it for said slice. A pharma can have it for Alz and a % of all sales, B for Rett, C for.... so on and so forth.
Then again BP is a greedy monster.
Exactly why I believed the patent wouldn't do much for pps near term, but in looking at it in terms of dubstep, we are nearing the DROP. Which direction is to be revealed soon enough.
Drop definition:
The part of a dubstep tune where it gets so incomprehensibly filthy that one cannot fathom - therefore, ones mind explodes.
How did everyone know it got approved months ago when one can easily look at the pair and see it approved just late last month, which since then didn't go near $6?
A temporary patch thought I assume?
Not a one and done, but for the rest of their lives.
Otherwise, the boat will spring a leak again and water resumes filling the boat.
Great analogy basparks
So then how does a piano test suffice?
Maybe handing a former artist a paint brush?
Or even being able to sit in front of a camera and be interviewed?
Very interested to see how these patients are after all these months.
Or are we to believe they too were misdiagnosed and "pretended" to have Alzheimer's ?
Curious question. In previous trials, has anyone improved from baseline or even held baseline for more than a couple months?
If a-273 can even hold the decline, we have a winner. PERIOD!!
Which is why I put my investment with a company that is willing to take risks and do medicine totally opposite of the norm. Since the norm has done the Alzheimer's community so well.
Soon, hopefully, we will all see what the "fire truck" did for the p2 participants.
Thanks Foodman for setting facts straight. One can easily say they were in attendance and he/she said this or that.
When we have good faith board members in attendance as well, it's a lot more difficult for those alternative facts to be believed.
Unless of course, somehow he/she had an EXCLUSIVE talk with the CEO.
??
I think even with a PR about patent were to come out on Tuesday, we won't get a pop some are hoping for. Hopefully though it'll be the start of a few milestones we need to achieve by eoy.
Well, if you want to speculate. No sneak peaks, but we got the Dr. buying shares the last 3 weeks. That means.......
Hmm.... so for the inexperienced investors on the board, it's like using Dawn dish washing soap vs Joy. Both are soaps to wash dishes, yet Dawn is much more effective in removing grease. And no, it's not in anyone's imagination. It has to be seen to believed. ??
Found this while looking for articles to read. Another thing that Anavex could potentially try and see if it's useful. We longs remember when our red head was at a brain trauma conference way back when.
Conclusion pill? Why can't it be A-273?
http://bleacherreport.com/articles/2728620-the-race-is-on-for-a-concussion-pill-as-new-nfl-season-begins?utm_source=cnn.com&utm_medium=referral&utm_campaign=editorial
Yup it's like leaving the football game down 6 points with 30 seconds left and the ball on the opponents 5 yard line. Leaving because you are frustrated they took a time out and you didn't want them to take one.
Just wait for the time out to be done and see if they win or not.
Patience
Hey Peter,
We appreciate the contributions and point of views you give to the board but could we stop using the word cure. It's a pretty bold statement to use with the information the company has given us so far.
Do what's best for you Bas. 28 months is a pretty long time. Although there really hasn't been and bad news yet released from them. For me, I'm in it to either be part of the shareholders that watch AVXL blossom or accept the fact that my entire investment will drastically be reduced.
You wouldn't be talking about this patent would you?
Try searching by patent number 9750746 ( which is application 13940352) at
https://portal.uspto.gov/pair/PublicPair
and the result will be
"Patent 9,750,746 is scheduled to be Issued on 09-05-2017"
I forget who it was that posted it earlier this week. Mikesc I think.
Which is why I'm glad falcon still posted his pps breakdown so everyone could see what COULD happen if all trials were positive.
Which would explain the stoppage of 375 share purchases.
Truth right there. At least there's the shareholder rights plan, so we don't totally get screwed if it ever came down to that.
Speculative facts, how ironic.
NTRP cure anything yet?
Don't forget about the tea leaves at the end of the rainbow. Oh, and tea leaves that are speculation-less.
The entire market is speculation Kid.
We will soon see what book the Anavex team is writing in the coming months.
If one did some DD, you'd have found that Missling was part of a few select invited guests to talk about .... in front of congressmen and the like. Want to know what that was, google is where you could start.
Did it have anything in their waiting or not Is anyone's guess.
On second thought, here you go since we have new members that may not have known about what happened in Feb 2017
http://www.anavex.com/anavex-life-sciences-ceo-joins-bio-ceo-investor-conference-2017-panel-designing-clinical-trials-in-21st-century-cures-paradigm/
Awesome, whats the chances that its a site created by the likes of "thee whom shall not be named?"
Tried searching about the registrar but only got it was registered on Jan 27 2017
Seems like the real deal.
Comparing oranges to apples KID. ??
Why waste money on animals when there is NOTHING that helps humans.
Down the road when money grows on trees for us, then maybe they could.
"This means" translates into your own reasoning then, correct? We all know which game plan that is.
Not getting me to sell anything. ??
This means maybe one should look for a company they believe in and trust instead of shorting and spreading false conclusions that have no merit or data to back up besides dig deeper, look better.
Blocked
All of that is possible, but so is the trial not panning out, the results not being ready at certain conferences leaving some upset and feeding into the sell-off vs letting the story be told in its own unique way.
We all hope. Longs hope for success, shorts hope for a price drop. Successes will always beat a price drop.
So with that mindset, I've been in AVXL since the otc days. They have since been releasing nothing but success. Reinforcing their board, strengthening their IP, or even making us investors want to hold even more because of the stockholders plan that got approved.
I've been tempted to sell and move to something that moves quicker, but I keep thinking of the quote. "The market is a device for transferring money from the impatient to the patient". So I've been holding and adding all this time. Even staying away from this board as it gets tiring to read and reread posts that try to get you to sell. Try to doubt your investment. I have 30 years before I retire and I have a pretty sizable investment of Anavex tied up in my 401K.
We finally may find out if our investment was worth the wait. I sure hope so and we revive continued success releases from the company.